Secondary Neutron and Photon Dose in Proton Therapy

Overview

Journal Radiother Oncol

Specialties Oncology
Radiology

Date 1999 Jan 30

PMID 9925249

Citations 30

Authors

S Agosteo

C Birattari

M Caravaggio

M Silari

G Tosi

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: The dose due to secondary neutrons and photons in proton therapy was estimated with Monte Carlo simulations. Three existing facilities treating eye and deep-seated tumours were taken into account. The results of the calculations related to eye proton therapy were verified with measurements.

Materials And Methods: The simulations were performed with the FLUKA code. Neutron fluence was measured inside an Alderson phantom (type ART) with activation techniques.

Results: The maximum dose due to secondaries produced in a passive beam delivery system was estimated to be of the order of 10(-4) and 10(-2) Gy per therapy Gy for eye and deep tumour treatments, respectively. In the case of irradiations of deep-seated tumours carried out with an active system, the dose was of the order of 10(-3) Gy per therapy Gy.

Conclusions: The dose due to secondaries depends on the geometry of the beam delivery system and on the energy of the primary beam and is lower in the healthy tissues distant from the target volume.

Citing Articles

On the Way to Accounting for Lung Modulation Effects in Particle Therapy of Lung Cancer Patients-A Review.

Witt M, Weber U, Flatten V, Stolzenberg J, Engenhart-Cabillic R, Zink K Cancers (Basel). 2024; 16(21).

PMID: 39518037 PMC: 11545780. DOI: 10.3390/cancers16213598.

Monte Carlo methods for device simulations in radiation therapy.

Park H, Paganetti H, Schuemann J, Jia X, Min C Phys Med Biol. 2021; 66(18).

PMID: 34384063 PMC: 8996747. DOI: 10.1088/1361-6560/ac1d1f.

Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.

Cartechini G, Fracchiolla F, Menegotti L, Scifoni E, La Tessa C, Schwarz M Radiat Oncol. 2020; 15(1):228.

PMID: 33008412 PMC: 7532613. DOI: 10.1186/s13014-020-01671-8.

Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers.

Jain V, Irmen P, OReilly S, Vogel J, Lin L, Lin A Int J Part Ther. 2020; 6(4):1-10.

PMID: 32582814 PMC: 7302732. DOI: 10.14338/IJPT-19-00076.1.

Independent application of an analytical model for secondary neutron equivalent dose produced in a passive-scattering proton therapy treatment unit.

Gallagher K, Taddei P Phys Med Biol. 2018; 63(15):15NT04.

PMID: 29978833 PMC: 6736632. DOI: 10.1088/1361-6560/aad1bc.